Amitell Capital Pte Ltd Buys Shares of 193,945 Waldencast plc (NASDAQ:WALD)

Amitell Capital Pte Ltd acquired a new stake in shares of Waldencast plc (NASDAQ:WALD - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 193,945 shares of the company's stock, valued at approximately $780,000. Waldencast comprises 0.6% of Amitell Capital Pte Ltd's holdings, making the stock its 27th largest holding. Amitell Capital Pte Ltd owned 0.16% of Waldencast as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also bought and sold shares of the company. Point72 Asia Singapore Pte. Ltd. raised its stake in Waldencast by 293.9% during the third quarter. Point72 Asia Singapore Pte. Ltd. now owns 6,854 shares of the company's stock valued at $25,000 after purchasing an additional 5,114 shares in the last quarter. SG Americas Securities LLC purchased a new stake in shares of Waldencast during the fourth quarter valued at $42,000. Wells Fargo & Company MN boosted its position in Waldencast by 29.9% in the 4th quarter. Wells Fargo & Company MN now owns 14,571 shares of the company's stock valued at $59,000 after buying an additional 3,358 shares during the period. Catalina Capital Group LLC grew its stake in Waldencast by 69.9% in the fourth quarter. Catalina Capital Group LLC now owns 27,102 shares of the company's stock worth $109,000 after purchasing an additional 11,154 shares in the last quarter. Finally, Barclays PLC grew its position in shares of Waldencast by 301.4% during the 3rd quarter. Barclays PLC now owns 32,436 shares of the company's stock worth $117,000 after buying an additional 24,355 shares in the last quarter. Hedge funds and other institutional investors own 41.97% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research firms have recently issued reports on WALD. DA Davidson reiterated a "buy" rating and set a $7.50 price objective on shares of Waldencast in a research note on Wednesday, March 19th. TD Cowen began coverage on shares of Waldencast in a research report on Monday, December 16th. They set a "hold" rating and a $4.30 target price on the stock. Finally, Telsey Advisory Group set a $5.00 price objective on shares of Waldencast in a research note on Thursday, March 20th. One research analyst has rated the stock with a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average price target of $5.56.

Waldencast Trading Down 3.2 %

Shares of WALD stock traded down $0.08 on Friday, reaching $2.44. 66,947 shares of the company were exchanged, compared to its average volume of 129,096. The company has a quick ratio of 0.78, a current ratio of 1.47 and a debt-to-equity ratio of 0.21. Waldencast plc has a 1 year low of $2.32 and a 1 year high of $6.44. The business has a 50-day moving average price of $3.07 and a 200 day moving average price of $3.33.

About Waldencast

Waldencast plc operates in the beauty and wellness business. The company engages in developing, acquiring, accelerating, and scaling various brands. It provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians.